Tumors

Next-generation sequencing has revolutionized the detection of tumor neoantigens

Researchers develop a non-invasive tool to measure antibody penetration of tumors

A blood test to diagnose and classify tumors could be revolutionary and practice-changing for patients and clinicians alike

The new test is specifically designed to analyze and classify high-grade serous ovarian cancer, the most common and lethal form of ovarian cancer

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies, and can guide treatment decisions for patients with Lynch-associated cancers

Next-generation gene sequencing finds mutations in patients resistant to PSMA-targeting therapy

Researchers have identified important drivers that enable tumors to change their behavior and evade anticancer therapies

In a recent study, several of the markers correlated strongly with known heart failure markers and also predicted which patients were most likely to die prematurely

Researchers recently developed a technique called representative sequencing, which builds a more accurate picture of a tumor's DNA

Collaboration co-led by researchers at St. Jude Children's Research Hospital discovers a novel predisposition gene in pediatric medulloblastoma